Key Laboratory of Bioorganic Synthesis of Zhejiang Province, College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou, China.
Engineering Research Center of Bioconversion and Biopurification of Ministry of Education, Zhejiang University of Technology, Hangzhou, China.
Biotechnol Bioeng. 2020 Feb;117(2):318-329. doi: 10.1002/bit.27203. Epub 2019 Nov 12.
Protein engineering is a powerful tool for improving the properties of enzymes. However, large changes in enzyme properties are still challenging for traditional evolution strategies because they usually require multiple amino acid substitutions. In this study, a feasible evolution approach by a combination of fragment swapping and semi-rational design was developed for the engineering of nitrilase. A chimera BaNIT harboring 12 amino acid substitutions was obtained using nitrilase from Arabis alpine (AaNIT) and Brassica rapa (BrNIT) as parent enzymes, which exhibited higher enantioselectivity and activity toward isobutylsuccinonitrile for the biosynthesis of pregabalin precursor. The semi-rational design was executed on BaNIT to further generate variant BaNIT/L223Q/H263D/Q279E with the concurrent improvement of activity, enantioselectivity, and solubility. The robust nitrilase displayed a 5.4-fold increase in whole-cell activity and the enantiomeric ratio (E) increased from 180 to higher than 300. Molecular dynamics simulation and molecular docking demonstrated that the substitution of residues on the A and C surface contributed to the conformation alteration of nitrilase, leading to the simultaneous enhancement of enzyme properties. The results obtained not only successfully engineered the nitrilase with great industrial potential for the production of pregabalin precursor, but also provided a new perspective for the development of novel industrially important enzymes.
蛋白质工程是改善酶性质的有力工具。然而,由于传统的进化策略通常需要多个氨基酸取代,因此对于酶性质的较大变化仍然具有挑战性。在这项研究中,通过片段交换和半理性设计的组合开发了一种可行的进化方法,用于腈酶的工程改造。使用高山南芥(AaNIT)和芸薹(BrNIT)的腈酶作为亲本酶,获得了具有 12 个氨基酸取代的嵌合体 BaNIT,该嵌合体对异丁基琥珀腈具有更高的对映选择性和活性,可用于合成普瑞巴林前体。对半理性设计的 BaNIT 进行了进一步的设计,以进一步生成同时提高活性、对映选择性和溶解性的变体 BaNIT/L223Q/H263D/Q279E。该稳健的腈酶的全细胞活性提高了 5.4 倍,对映体比率(E)从 180 增加到 300 以上。分子动力学模拟和分子对接表明,A 和 C 表面残基的取代有助于腈酶构象的改变,从而同时增强了酶的性质。研究结果不仅成功地工程改造了具有巨大工业潜力的腈酶,用于生产普瑞巴林前体,而且为新型工业重要酶的开发提供了新的视角。